Marcos Espinal

From Wikipedia, the free encyclopedia
Jump to: navigation, search

Marcos Espinal was the Executive Secretary of the Stop TB Partnership from September 2003 until August 2010. Before his appointment as Executive Secretary, Dr Espinal was the manager of the Initiative of the DOTS Plus - Stop TB Department at the World Health Organization in Geneva. Dr Espinal is currently the Area Manager for Health Surveillance, Disease Prevention and Control for the Panamerican Health Organization.



Espinal holds a medical degree from the Universidad Autónoma de Santo Domingo in the Dominican Republic, specializing in Pediatrics Children's Hospital Robert Reid of Santo Domingo. Subsequently he completed his Master's and Ph.D. degrees in Public Health at the University of California, Berkeley.


After graduating from Berkeley returned to the Dominican Republic where he worked for 4 years in the National Research Center for Maternal and Infant Health that several investigations tuberculosis, HIV / AIDS and other infectious diseases. In 1996, he was awarded scientist of the International Union Against Tuberculosis and Lung Disease

Espinal joined WHO in 1997 to lead the WHO / IUATLD Global Project on Drug Resistance Surveillance. In 2000 he became responsible for the newly established DOTS-Plus initiative for the management of MDR-TB, including activities of the Stop TB Partnership Working Group on DOTS-Plus for MDR-TB and the WHO hosts Green Light Committee, a partnership initiative he has successfully introduced projects for the management of MDR-TB with second-line drugs in more than 40 countries. He was also responsible for coordinating the activities of DOTS expansion to the Americas Region of the WHO.

Jobs include previous Research Scientist at the New York City Department of Public Health HIV / AIDS Program Monitoring and Research Coordinator of the National Center for Maternal and Child Health Research, Dominican Republic.

Published works[edit]

In recent years, Espinal has published more than 50 papers mostly in the field of TB, MDR-TB and HIV.